» Articles » PMID: 1407970

Proliferative Vitreoretinopathy. Lymphocytes in Epiretinal Membranes

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 1992 Sep 1
PMID 1407970
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the potential contribution of inflammatory and immune-mediated processes contributing to the pathogenesis of proliferative vitreoretinopathy (PVR), an immunohistochemical study was undertaken to characterize the infiltrating inflammatory cells in epiretinal membranes surgically removed from the eyes of patients with PVR.

Methods: Twenty-one epiretinal membranes obtained surgically from eyes with PVR complicating rhegmatogenous retinal detachment were studied immunohistochemically using the ABC technique and a panel of monoclonal and polyclonal antibodies.

Results: T lymphocytes were found in 18 of the 21 specimens and generally constituted a small percentage of the total cell number. CD4+ T cells were found in 14 of the 18 membranes containing T cells. Three of six frozen membranes contained T cells that were positive for the interleukin-2 receptor. In 5 of 16 membranes studied, cells positive for the macrophage/monocyte marker were found. No B lymphocytes or neutrophils were identified, and there were no deposits of complement or immunoglobulins. Positive staining for the class II MHC antigen HLA-DR was found in 7 of the 21 membranes, a result that was more consistent in frozen than in fixed tissues.

Conclusion: The study suggests that T lymphocytes are present in PVR epiretinal membranes and may be activated. These cells have the potential to play a role in the pathobiology of PVR.

Citing Articles

Fibrotic Changes in Rhegmatogenous Retinal Detachment.

Harju N, Kauppinen A, Loukovaara S Int J Mol Sci. 2025; 26(3).

PMID: 39940795 PMC: 11817287. DOI: 10.3390/ijms26031025.


Transition to Chronic Fibrosis in an Animal Model of Retinal Detachment With Features of Proliferative Vitreoretinopathy.

Peterson C, Lu Y, Santiago C, Price A, McNally M, Schubert W Invest Ophthalmol Vis Sci. 2023; 64(15):39.

PMID: 38153753 PMC: 10756252. DOI: 10.1167/iovs.64.15.39.


Proliferative Vitreoretinopathy: A Reappraisal.

Carpineto P, Licata A, Ciancaglini M J Clin Med. 2023; 12(16).

PMID: 37629329 PMC: 10455099. DOI: 10.3390/jcm12165287.


Effect of Esculetin on -Butyl Hydroperoxide-Induced Oxidative Injury in Retinal Pigment Epithelial Cells In Vitro.

Jung W, Park S, Yu H, Kim Y, Kim J Molecules. 2022; 27(24).

PMID: 36558102 PMC: 9781126. DOI: 10.3390/molecules27248970.


Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice.

Chen S, Lin Y, Wang L, Tsai H, Yang C, Teng Y Int J Mol Sci. 2021; 22(21).

PMID: 34769100 PMC: 8584209. DOI: 10.3390/ijms222111670.